498 Metastatic high grade serous ovarian cancer has an immune excluded tumor microenvironment – explaining failure of immunotherapy to date

K Glennon; A Treacy; K Slattery; S Cunningham; JMC Cormack; A Fabre; W Kolch; L Lynch; D Brennan

doi:10.1136/ijgc-2021-ESGO.415

Article info

Ovarian cancer

498 Metastatic high grade serous ovarian cancer has an immune excluded tumor microenvironment – explaining failure of immunotherapy to date

Free

Authors

K Glennon UCD School of Medicine, Mater Misericordiae University Hospital, Department of Gynaecological Oncology, Dublin, Ireland PubMed articles Google scholar articles
A Treacy Mater Misericordiae University Hospital, Department of Pathology, Dublin, Ireland PubMed articles Google scholar articles
K Slattery Trinity College Dublin, School of Biochemistry and Immunology, Dublin, Ireland PubMed articles Google scholar articles
S Cunningham Trinity College Dublin, School of Biochemistry and Immunology, Dublin, Ireland PubMed articles Google scholar articles
JMC Cormack Conway Institute, UCD School of Medicine, Department of Pathology, Dublin, Ireland PubMed articles Google scholar articles
A Fabre Conway Institute, UCD School of Medicine, Department of Pathology, Dublin, Ireland PubMed articles Google scholar articles
W Kolch UCD School of Medicine,, Systems biology Ireland, Dublin, Ireland PubMed articles Google scholar articles
L Lynch Trinity College Dublin, School of Biochemistry and Immunology, Dublin, Ireland PubMed articles Google scholar articles
D Brennan UCD School of Medicine, Mater Misericordiae University Hospital, Department of Gynaecological Oncology, Dublin, Ireland UCD School of Medicine,, Systems biology Ireland, Dublin, Ireland PubMed articles Google scholar articles

Citation

Glennon K, Treacy A, Slattery K, et al

498 Metastatic high grade serous ovarian cancer has an immune excluded tumor microenvironment – explaining failure of immunotherapy to date

International Journal of Gynecologic Cancer 2021;31:A241-A244.

Publication history

First published October 12, 2021.

Online issue publication

January 10, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password